ANTX · AN2 Therapeutics, Inc.

$5.66 +0.03 (+0.53%) At close · Aug 25

Market Cap

$213.02M

37.74M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-11	—
10-Q	2026-08-11	2026-06-30
8-K	2026-06-09	2026-06-03
Investor Event Transcript	2026-06-04	2026-06-30
8-K	2026-06-04	—
8-K	2026-05-11	—
10-Q	2026-05-11	2026-03-31
DEF 14A	2026-04-22	—
8-K	2026-04-09	—
8-K	2026-03-20	2026-03-19
10-K	2026-03-17	2025-12-31
8-K	2026-03-17	—
8-K	2026-03-10	2026-03-08
8-K	2026-01-29	2026-01-26
8-K	2025-11-12	—
10-Q	2025-11-12	2025-09-30
10-Q	2025-08-12	2025-06-30
8-K	2025-08-12	—
8-K	2025-06-20	2025-06-17
8-K	2025-06-11	—
8-K	2025-05-27	2025-05-22
8-K	2025-05-13	—
10-Q	2025-05-13	2025-03-31
8-K	2025-05-01	—
DEF 14A	2025-04-10	—
10-K	2025-03-25	2024-12-31
8-K	2025-03-25	—
10-Q	2024-11-13	2024-09-30
8-K	2024-11-13	—
8-K	2024-11-05	2024-11-04
8-K	2024-08-19	2024-08-15
10-Q	2024-08-13	2024-06-30
8-K	2024-08-13	—
8-K	2024-08-08	2024-08-07
8-K	2024-06-24	2024-06-19
10-K/A	2024-05-14	2023-12-31
8-K	2024-05-14	—
10-Q	2024-05-14	2024-03-31
DEF 14A	2024-04-26	2024-06-19
10-K	2024-03-29	2023-12-31
8-K	2024-03-28	—
8-K	2024-02-12	—
10-Q	2023-11-09	2023-09-30
8-K	2023-11-09	—
8-K	2023-09-13	—
8-K	2023-09-08	2023-09-01
8-K	2023-08-16	2023-08-15
8-K	2023-08-10	—
10-Q	2023-08-10	2023-06-30
8-K	2023-06-09	2023-06-07

Showing 1–50 of 64 filings

Key facts CIK 1880438 CUSIP 037326105 13F (30d) 64 filings 64 filers Visit website Investor relations